Exhibit 10.2
Confidential Materials omitted and filed separately with the
Securities and Exchange Commission. Asterisks denote omissions.
AMENDMENT NO. 1 TO
AGREEMENT
THIS AMENDMENT NO. 1 TO AGREEMENT (this “Amendment”) is made effective as of the 1st day of January, 2005, between IDEXX Europe B.V., a corporation organized under the laws of The Netherlands whose principal place of business is at Koolhovenlaan 20, 1119 NE — Schiphol-Rijk, The Netherlands (“IDEXX”), and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A.(“OCD”).
WHEREAS, OCD and IDEXX entered into a certain Agreement dated as of October 17, 2003 (the “Agreement”) regarding supply by OCD of dry slides for IDEXX veterinary chemistry analyzers; and
WHEREAS, OCD and IDEXX desire to amend the Agreement as set forth in this Amendment.
NOW THEREFORE, the parties hereby agree as follows:
1. Capitalized terms used in this Amendment, which are not otherwise defined, have the respective meanings ascribed to them in the Agreement.
2. Section 18.01 is amended by deleting the same in its entirety and substituting therefor the following provision:
| Subject to the terms and conditions set forth herein, the term (the “Term”) of the Agreement shall be the period from the Commencement Date until December 31, 2020. |
3. Schedule 3,Schedule 5,Schedule 6 andSchedule 8 to the Agreement are amended by deleting the same in their entirety and substituting therefor the respectiveSchedule 3,Schedule 5,Schedule 6 andSchedule 8attached to this Amendment.
4. The price for Vetrol controls (Catalog No. 8699852) supplied hereunder shall be $[**] and the price for tips (Catalog No. 6801762) supplied hereunder shall be $[**].
5. The per slide prices for single VETTEST slides that are packaged 12 per box shall be the same as the per slide prices of the corresponding single VETTEST slides that are packaged 25 per box.
6. Except as modified by this Amendment, all provisions of the Agreement shall continue in full force and effect.
IN WITNESS WHEREOF and intending to be legally bound, the parties hereto have caused this Amendment to be duly executed in duplicate by their respective authorized representatives as of the day and year first written above.
ORTHO-CLINICAL DIAGNOSTICS, INC. | | IDEXX EUROPE B.V. |
---|
| | |
By: /s/Tony Zezzo | | By: /s/Conan R. Deady |
| |
|
Name: Tony Zezzo | | Name: Conan R. Deady |
| |
|
Title: VP Americas | | Title: Director |
| |
|
| | |
| | Acknowledged and consented to, |
| | solely as guarantor pursuant to |
| | Section 30 of the Agreement |
| | |
| | IDEXX LABORATORIES, INC. |
| | |
| | By: /s/Conan R. Deady |
| |
|
| | Name: Conan R. Deady |
| |
|
| | Title: Vice President |
| |
|
Schedule 3 — Panels/Profiles
(Applicable only to VETTEST Analyzer)
The initial PANEL shall be the “Pre-Anesthetic Panel” consisting of four sets of the following six VETTEST slides:
| |
---|
BUN | Urea Nitrogen |
ALT | Alanine aminotransferase |
GLU | Glucose |
TP | Total protein |
CREA | Creatinine |
ALKP | Alkaline phosphatase |
|
The initial PROFILES shall be the “General Health Profile” and the “Large Animal Profile”, each consisting of two sets of 12 VETTEST slides as follows:
General Health Profile | | Large Animal Profile | |
---|
ALB | Albumin | ALB | Albumin |
ALKP | Alkaline phosphatase | ALKP | Alkaline phosphatase |
ALT(SGPT) | Alanine aminotransferase | AST | AST |
AMYL | Amylase | Ca2+ | Calcium |
Ca2+ | Calcium | CK | CK |
CHOL | Cholesterol | GGT | Gamma GT |
CREA | Creatinine | GLU | Glucose |
GLU | Glucose | PHOS | Inorganic phosphate |
PHOS | Inorganic phosphate | LDH | LDH |
TBIL | Total bilirubin | MG | Magnesium |
TP | Total protein | TP | Total Protein |
BUN | Urea Nitrogen | BUN | Urea Nitrogen |
Effective as of March 4, 2004, “PROFILES” shall also include the “Equine Health Profile,” consisting of two sets of 12 VETTEST slides as follows:
| |
---|
ALB | Albumin |
ALKP | Alkaline phosphatase |
AST | AST |
Ca2+ | Calcium |
CK | CK |
GGT | Gamma GT |
GLU | Glucose |
LDH | LDH |
TP | Total protein |
BUN | Urea Nitrogen |
CREA | Creatinine |
TBIL | Total Bilirubin |
Effective as of May 25, 2004, “PROFILES” shall also include the “Urine P:C Ratio” (OCD cat #6802061), consisting of six pairs of Urine Protein and Creatinine VETTEST slides.
Effective as of June 1, 2005, “PANELS” shall also include the “[**]” (IDEXX part #98-13952-00, OCD cat #6802213), consisting of four sets of the following [**] VETTEST slides:
| |
---|
[**] | [**] |
[**] | [**] |
[**] | [**] |
[**] | [**] |
[**] | [**] |
[**] | [**] |
Packaging for the Pre-Anesthetic Panels, the General Health Profiles, the Large Animal Profiles, the Equine Health Profiles, the Urine P:C Ratios and the [**] for the VETTEST Analyzer has been previously agreed upon by the parties, and any changes to the slide composition or packaging of the foregoing PANELS or PROFILES shall be negotiated in good faith and mutually agreed upon by OCD and IDEXX. The slide composition, packaging and initial pricing of any additional PANELS/PROFILES shall be mutually agreed upon by OCD and IDEXX. Unless otherwise agreed by the parties in writing with respect to one or more specific PANELS or PROFILES, all purchases by IDEXX or IDEXX US of VETTEST slides packaged as PANELS/PROFILES shall be credited against the Annual Purchase Forecasts and Purchase Commitments for such slides under this Agreement and the US Agreement.
New Slide/Panel Design for the New Analyzer shall be as developed by IDEXX US under Article 3 of the US Agreement.
Schedule 5 - Products
(as of January 1, 2005)
Single Slides (Box of 25)
| Catalog Number
| Single Slides (Box of 12) (added Dec 11, 2003)
| Catalog Number
|
---|
Albumin | | | 822 7134 | | | Albumin | | | 6801907 | | |
Alk Phos | | | 831 5459 | | | Alk Phos | | | 6801919 | | |
ALT | | | 808 3750 | | | ALT | | | 6801916 | | |
Ammonia | | | 181 6842 | | | Ammonia | | | 6801908 | | |
Amylase | | | 820 8191 | | | Amylase | | | 6801913 | | |
AST | | | 811 3979 | | | AST | | | 6801914 | | |
Calcium | | | 804 8191 | | | Calcium | | | 6801902 | | |
Cholesterol | | | 835 4888 | | | Cholesterol | | | 6801906 | | |
CK | | | 835 8582 | | | CK | | | 6801918 | | |
Creatinine | | | 818 3477 | | | Creatinine | | | 6801911 | | |
ECO2 (HCO3) | | | 853 8670 | | | ECO2 (HCO3) | | | 6802306 | | |
Gamma GT | | | 826 1315 | | | Gamma GT | | | 6801920 | | |
Glucose | | | 813 0536 | | | Glucose | | | 6801900 | | |
LDH | | | 835 1082 | | | LDH | | | 6801917 | | |
Lipase | | | 196 6191 | | | Lipase | | | 6801915 | | |
Magnesium | | | 108 0266 | | | Magnesium | | | 6801912 | | |
Phosphorus | | | 807 0856 | | | Phosphorus | | | 6801909 | | |
Total Bilirubin | | | 838 0396 | | | Total Bilirubin | | | 6801910 | | |
Total Protein | | | 193 7093 | | | Total Protein | | | 6801904 | | |
Triglycerides | | | 192 2285 | | | Triglycerides | | | 6801905 | | |
Urea Nitrogen | | | 150 7326 | | | Urea Nitrogen | | | 6801901 | | |
Uric Acid | | | 100 0793 | | | Uric Acid | | | 6801903 | | |
| | | | | | | | | | | |
| | | | | | [**] (added as of July 1, 2005) | | | 6802307 | | |
Profile Slides (Box of 24)
| | Profile Slides (Box of 12)
| |
---|
General Health Profile | | | 160 7175 | | | Urine P;C Ratio (added May 25, 2004) | | | 6802061 | | |
Pre-Anesthetic Panel | | | 801 5109 | | | | | | | | |
Large Animal Profile | | | 680 0071 | | | | | | | | |
Equine Health Panel (added Mar 4, 2004) | | | 680 1956 | | | | | | | | |
[**] (added as of June 1, 2005) | | | 680 2213 | | | | | | | | |
Other
| | | |
---|
Vetrols | | | 869 9852 | | | | | | | | |
Tips | | | 6801762 | | | | | | | | |
Schedule 6 – Minimum Prices for New Chemistries
Urine Protein (added May 25, 2004 as part of the Urine P:C Ratio):
| • | Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $[**] per slide. |
[**] (added as of July 1, 2005):
| • | Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $[**] per slide. |
Schedule 8 – Eligible New Chemistry Slides
| |
---|
[**] | |
[**] | |
[**] | |
[**] | |
[**] | |
[**] | |
[**] | |
[**] | |
[**] | |
[**] | |
[**] | |